Home/Dexcom/Jereme Sylvain

JS

Jereme Sylvain

EVP, Chief Financial Officer

Therapeutic Areas

Diabetes Metabolic Health

Dexcom Pipeline

Drug	Indication	Phase
Dexcom G7 CGM	Type 1 and Type 2 Diabetes	Commercial
Dexcom G7 15 Day	Type 1 and Type 2 Diabetes	Commercial
Stelo Glucose Biosensor	Over-the-counter metabolic health monitoring	Commercial

Leadership Team at Dexcom

President & Chief Executive Officer

EVP, Chief Commercial Officer

Girish Naganathan

EVP, Chief Technology Officer

EVP, Chief Legal Officer

EVP, Global Business Services, Regulatory, Medical and Clinical Affairs

EVP, Strategy & Corporate Development

EVP, Chief Human Resources Officer

Chairman of the Board

Steven R. Altman

View full Dexcom profile